- Home
- VIPS vs RYTM Comparison
VIPS vs RYTM Comparison
Compare VIPS & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIPS
- RYTM
- Stock Information
- Founded
- VIPS 2008
- RYTM 2008
- Country
- VIPS China
- RYTM United States
- Employees
- VIPS N/A
- RYTM N/A
- Industry
- VIPS Catalog/Specialty Distribution
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- VIPS Consumer Discretionary
- RYTM Health Care
- Exchange
- VIPS Nasdaq
- RYTM Nasdaq
- Market Cap
- VIPS 8.5B
- RYTM 6.9B
- IPO Year
- VIPS 2012
- RYTM 2017
- Fundamental
- Price
- VIPS $17.85
- RYTM $97.78
- Analyst Decision
- VIPS Buy
- RYTM Strong Buy
- Analyst Count
- VIPS 5
- RYTM 13
- Target Price
- VIPS $18.33
- RYTM $101.92
- AVG Volume (30 Days)
- VIPS 2.6M
- RYTM 572.4K
- Earning Date
- VIPS 08-14-2025
- RYTM 11-04-2025
- Dividend Yield
- VIPS 2.67%
- RYTM N/A
- EPS Growth
- VIPS N/A
- RYTM N/A
- EPS
- VIPS 1.86
- RYTM N/A
- Revenue
- VIPS $14,793,082,721.00
- RYTM $156,287,000.00
- Revenue This Year
- VIPS $0.63
- RYTM $44.69
- Revenue Next Year
- VIPS $2.09
- RYTM $63.53
- P/E Ratio
- VIPS $9.68
- RYTM N/A
- Revenue Growth
- VIPS N/A
- RYTM 53.55
- 52 Week Low
- VIPS $12.14
- RYTM $45.91
- 52 Week High
- VIPS $18.53
- RYTM $106.52
- Technical
- Relative Strength Index (RSI)
- VIPS 67.26
- RYTM 50.10
- Support Level
- VIPS $16.49
- RYTM $96.73
- Resistance Level
- VIPS $18.53
- RYTM $102.46
- Average True Range (ATR)
- VIPS 0.36
- RYTM 3.22
- MACD
- VIPS 0.07
- RYTM -1.23
- Stochastic Oscillator
- VIPS 68.14
- RYTM 10.93
About VIPS Vipshop Holdings Limited
Vipshop is a leading Chinese online discount retailer offering branded products at attractive discounts ranging from 10%-90% off their original price through daily flash sales. It operates warehousing, retailing, product procurements, software development, and information technology support in-house while outsourcing to third-party logistics providers for distribution and shipments. Branded products on Vipshop's platform are sourced mostly through a consignment model with global brand partners . As of March 31, 2025, Eric Ya Shen, chairman and CEO, had 64.5% voting rights. Leading Chinese social media firm and strategic shareholder Tencent also holds an 12.5% interest.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.